+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acetylcholine"

Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 80 Pages
  • Global
From
Myasthenia Gravis Treatment Global Market Report 2024 - Product Thumbnail Image

Myasthenia Gravis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Muscarinic Acetylcholine Receptor Global Market Report 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Migraine Drugs: Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs: Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2024-2032 - Product Thumbnail Image

Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2024-2032

  • Report
  • March 2024
  • 139 Pages
  • Global
From
Migraine Drugs Market Report by Treatment Type, Drug Type, Route of Administration, Distribution Channel, and Region 2023-2028 - Product Thumbnail Image

Migraine Drugs Market Report by Treatment Type, Drug Type, Route of Administration, Distribution Channel, and Region 2023-2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Parkinson's disease - Pipeline Insight, 2024 - Product Thumbnail Image

Parkinson's disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Spasticity - Pipeline Insight, 2024 - Product Thumbnail Image

Spasticity - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 106 Pages
  • Global
From
Diabetic Peripheral Neuropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Peripheral Neuropathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Dystonia - Pipeline Insight, 2024 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024 - Product Thumbnail Image

Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Dementia with Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia with Diabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Spasmodic-torticollis - Pipeline Insight, 2024 - Product Thumbnail Image

Spasmodic-torticollis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • April 2024
  • 287 Pages
  • Global
From
Cervical Dystonia Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Cervical Dystonia Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 150 Pages
  • Global
From
Postherpetic Neuralgia - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Postherpetic Neuralgia - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 141 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor (mAChR) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor (mAChR) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Acetylcholine market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Acetylcholine is a neurotransmitter that plays a role in muscle contraction, memory, and learning. It is used to treat conditions such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis. Acetylcholine is available in both oral and injectable forms, and is often used in combination with other drugs. The Acetylcholine market is highly competitive, with many companies offering products. Some of the major players in the market include Pfizer, Novartis, Merck, GlaxoSmithKline, and Sanofi. Other companies include Allergan, Teva Pharmaceuticals, and Mylan. Show Less Read more